Filed 27d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
AbbVie
ABBV
$50K-$100K
+5.1% vs S&P 500
Trade dateMay 8, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 190
Filed 27d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Vertex Pharmaceuticals
VRTX
$15K+
Trade dateMay 8, 2026
Filed 4mo ago· Feb 2, 2026
4 days to disclose
David J. Taylor
RHouseOhio-02
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
−3.5% vs S&P 500
Trade dateJan 29, 2026
-
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 4mo ago· Jan 13, 2026
36 days to disclose
Julia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
−1.9% vs S&P 500
Trade dateDec 8, 2025
Filed 4mo ago· Jan 13, 2026
260 days to disclose · 215 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+6.5% vs S&P 500
Trade dateApr 28, 2025
Filed 4mo ago· Jan 13, 2026
354 days to disclose · 309 past 45-day windowJulia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−9.1% vs S&P 500
Trade dateOct 23, 2024
-
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+17.6% vs S&P 500
Trade dateOct 23, 2024
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
21 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Novo Nordisk
NVO
$1K-$15K
−11.5% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+18.1% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
−7.1% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 22, 2025
27 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+10.7% vs S&P 500
Trade dateSep 25, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 22, 2025
41 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Novo Nordisk
NVO
$1K-$15K
−22.0% vs S&P 500
Trade dateSep 11, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 22, 2025
41 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+9.9% vs S&P 500
Trade dateSep 11, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 20, 2025
5 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$1K-$15K
−23.5% vs S&P 500
Trade dateOct 15, 2025
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
AstraZeneca
AZN
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Depositary Shares
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Gilead Sciences
GILD
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Elanco Animal Health
ELAN
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Common Stock
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
Merck
MRK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Stock
Filed 7mo ago· Oct 10, 2025
17 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
GSK PLC
GSK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 8mo ago· Sep 12, 2025
21 days to disclose
John Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+7.5% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+14.0% vs S&P 500
Trade dateAug 11, 2025
Filed 8mo ago· Sep 12, 2025
36 days to discloseVal T. Hoyle
DHouseOregon-04
↓sold
BioNTech
BNTX
$1K-$15K
+15.1% vs S&P 500
Trade dateAug 7, 2025
Shares
Filed 8mo ago· Sep 12, 2025
39 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+11.7% vs S&P 500
Trade dateAug 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
129 days to disclose · 84 past 45-day windowVal T. Hoyle
DHouseOregon-04
↓sold
Eli Lilly
LLY
$1K-$15K
+10.6% vs S&P 500
Trade dateMay 6, 2025
Filed 8mo ago· Sep 12, 2025
298 days to disclose · 253 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
GSK PLC
GSK
$1K-$15K
+45.4% vs S&P 500
Trade dateNov 18, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Merck
MRK
$1K-$15K
+12.2% vs S&P 500
Trade dateOct 29, 2024
Stock
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Gilead Sciences
GILD
$1K-$15K
+37.9% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Novo Nordisk
NVO
$1K-$15K
−57.6% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.5% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+4.1% vs S&P 500
Trade dateOct 29, 2024
Common Stock
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Eli Lilly
LLY
$1K-$15K
+32.3% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
AstraZeneca
AZN
$1K-$15K
+42.9% vs S&P 500
Trade dateOct 29, 2024
Depositary Shares
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Sep 2, 2025
26 days to discloseDavid J. Taylor
RHouseOhio-02
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−2.9% vs S&P 500
Trade dateAug 7, 2025
-
Filed 9mo ago· Aug 29, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$1K-$15K
−27.3% vs S&P 500
Trade dateAug 28, 2025
Filed 9mo ago· Aug 20, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Novo Nordisk
NVO
$15K-$50K
−25.1% vs S&P 500
Trade dateAug 19, 2025
Filed 9mo ago· Aug 20, 2025
40 days to disclose
Ritchie Torres
DHouseNew York-15
↓sold
AbbVie
ABBV
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
AbbVie
ABBV
$1K-$15K
−21.2% vs S&P 500
Trade dateSep 26, 2024
Filed 9mo ago· Aug 15, 2025
11 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
−2.3% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to disclose
Scott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
+5.6% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+11.2% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
34 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Novo Nordisk
NVO
$1K-$15K
+8.9% vs S&P 500
Trade dateJul 10, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+16.2% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
+6.6% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+16.3% vs S&P 500
Trade dateJun 11, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
63 days to disclose · 18 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 11, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
64 days to disclose · 19 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Novartis Ag
NVS
$1K-$15K
+9.5% vs S&P 500
Trade dateJun 10, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
64 days to disclose · 19 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+9.5% vs S&P 500
Trade dateJun 10, 2025
-
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
65 days to disclose · 20 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Novartis Ag
NVS
$1K-$15K
+15.0% vs S&P 500
Trade dateJun 9, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
65 days to disclose · 20 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Novo Nordisk
NVO
$1K-$15K
−50.1% vs S&P 500
Trade dateJun 9, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
245 days to disclose · 200 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Vertex Pharmaceuticals
VRTX
$1K-$15K
−14.5% vs S&P 500
Trade dateDec 11, 2024
-
⚑ Pharmaceutical
Filed 11mo ago· Jul 3, 2025
9 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+11.0% vs S&P 500
Trade dateJun 24, 2025
Common Stock
⚑ Pharmaceutical
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Vertex Pharmaceuticals
VRTX
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
-
Filed 11mo ago· Jun 22, 2025
45 days to disclose
Laurel M. Lee
RHouseFlorida-15
↓sold
Novo Nordisk
NVO
$1K-$15K
+10.7% vs S&P 500
Trade dateMay 8, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jun 11, 2025
20 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+6.0% vs S&P 500
Trade dateMay 22, 2025
Filed 12mo ago· Jun 9, 2025
25 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+4.1% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 14, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+4.7% vs S&P 500
Trade dateApr 3, 2025
Filed 1.1y ago· May 14, 2025
43 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+2.4% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· May 9, 2025
32 days to disclose
Jared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+6.8% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 8, 2025
21 days to discloseJefferson Shreve
RHouseIndiana-06
↓sold
AbbVie
ABBV
$50K-$100K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
AbbVie
ABBV
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+2.5% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· Apr 23, 2025
30 days to disclose
George Whitesides
DHouseCalifornia-27
↓sold
Novartis Ag
NVS
$100K-$250K
+2.2% vs S&P 500
Trade dateMar 24, 2025
Filed 1.1y ago· Apr 17, 2025
14 days to disclose
Dwight Evans
DHousePennsylvania-03
↓sold
AbbVie
ABBV
$1K-$15K
+3.8% vs S&P 500
Trade dateApr 3, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 14, 2025
25 days to disclose
Byron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Novo Nordisk
NVO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 14, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Vertex Pharmaceuticals
VRTX
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
-
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.1y ago· Apr 11, 2025
29 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−19.4% vs S&P 500
Trade dateMar 13, 2025
-
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+5.2% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 19, 2025
2 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
−0.6% vs S&P 500
Trade dateMar 17, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Vertex Pharmaceuticals
VRTX
$15K-$50K
−13.1% vs S&P 500
Trade dateFeb 24, 2025
-
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
AbbVie
ABBV
$50K-$100K
+6.5% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+20.2% vs S&P 500
Trade dateJan 15, 2025
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+20.2% vs S&P 500
Trade dateJan 15, 2025
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
AbbVie
ABBV
$1K-$15K
+21.2% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.0% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Amgen
AMGN
$1K-$15K
+18.4% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−10.8% vs S&P 500
Trade dateDec 6, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.5y ago· Nov 21, 2024
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+24.6% vs S&P 500
Trade dateNov 20, 2024
Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
AbbVie
ABBV
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 27d ago | Donald J. Trump RPOTUSFlorida | ↑bought | AbbVie ABBV | May 8, 2026 | Good buy·+$4.8K+6.3% +5.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2026 27d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Vertex Pharmaceuticals VRTX | May 8, 2026 | price pending | $15K+ midpoint $15K |
Feb 2, 2026 4mo ago | David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Dec 8, 2025 36 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Apr 28, 2025 260 days to disclose · 215 past 45-day window | Good buy·+$1.1K+13.7% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Jan 24, 2025 354 days to disclose · 309 past 45-day window | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Vertex Pharmaceuticals VRTX - | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$826-10.3% −9.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$1.3K+16.4% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Bad buy·−$684-8.6% −11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$1.7K+21.0% +18.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Bad buy·−$335-4.2% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 22, 2025 7mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 25, 2025 27 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 22, 2025 7mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 11, 2025 41 days to disclose | Bad buy·−$1.3K-15.7% −22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 22, 2025 7mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Sep 11, 2025 41 days to disclose | Good buy·+$1.3K+16.2% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2025 7mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Oct 15, 2025 5 days to disclose | Bad buy·−$1.5K-19.3% −23.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | AstraZeneca AZN Depositary Shares | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Johnson & Johnson JNJ | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Gilead Sciences GILD | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Elanco Animal Health ELAN Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Merck MRK Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | GSK PLC GSK | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 22, 2025 21 days to disclose | Flat·+0.0% +7.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 11, 2025 32 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | BioNTech BNTX Shares | Aug 7, 2025 36 days to disclose | Flat·+0.0% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | GSK PLC GSK | Nov 18, 2024 298 days to disclose · 253 past 45-day window | Good buy·+$4K+50.0% +45.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Merck MRK Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$980+12.2% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Gilead Sciences GILD | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3K+38.0% +37.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Novo Nordisk NVO | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$4.6K-57.5% −57.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Johnson & Johnson JNJ | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.8K+47.6% +47.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$333+4.2% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Eli Lilly LLY | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$2.6K+32.4% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.4K+42.9% +42.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | David J. Taylor RHouseOhio-02 | ↑bought | Vertex Pharmaceuticals VRTX - | Aug 7, 2025 26 days to disclose | Good buy·+$977+12.2% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 28, 2025 1 day to disclose | Bad buy·−$1.5K-18.4% −27.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 19, 2025 1 day to disclose | Bad buy·−$5.4K-16.5% −25.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | AbbVie ABBV | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | AbbVie ABBV | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$284+3.5% −21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Aug 4, 2025 11 days to disclose | Good buy·+$749+9.4% −2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$2K-6.2% −17.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Good buy·+$1.3K+16.9% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 10, 2025 34 days to disclose | Flat·+0.0% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$2.2K+27.4% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$1.4K+17.9% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Good buy·+$2.1K+25.7% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 10, 2025 64 days to disclose · 19 past 45-day window | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 10, 2025 64 days to disclose · 19 past 45-day window | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novartis Ag NVS ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 9, 2025 65 days to disclose · 20 past 45-day window | Good buy·+$2.1K+25.7% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Novo Nordisk NVO ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 9, 2025 65 days to disclose · 20 past 45-day window | Bad buy·−$3.1K-39.4% −50.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$799-10.0% −14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Virginia Foxx RHouseNorth Carolina-05 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 9 days to disclose | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Vertex Pharmaceuticals VRTX - | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | Laurel M. Lee RHouseFlorida-15 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Energy and Commerce | May 8, 2025 45 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | May 22, 2025 20 days to disclose | Good buy·+$1.6K+19.8% +6.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$1.4K+18.0% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Apr 17, 2025 27 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 3, 2025 41 days to disclose | Good buy·+$675+8.4% +4.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 1, 2025 43 days to disclose | Good buy·+$480+6.0% +2.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Apr 7, 2025 32 days to disclose | Good buy·+$1.4K+17.2% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | AbbVie ABBV | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | May 5, 2025 1 day to disclose | Good buy·+$799+10.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | George Whitesides DHouseCalifornia-27 | ↓sold | Novartis Ag NVS | Mar 24, 2025 30 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 17, 2025 1.1y ago | Dwight Evans DHousePennsylvania-03 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Ways and Means | Apr 3, 2025 14 days to disclose | Flat·+0.0% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Novo Nordisk NVO | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$2.8K-34.8% −37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$11.3K-34.8% −37.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$5.3K-16.2% −19.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$399+5.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 19, 2025 1.2y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Mar 17, 2025 2 days to disclose | Good buy·+$44+0.6% −0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Feb 24, 2025 13 days to disclose | Bad buy·−$4.1K-12.5% −13.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | AbbVie ABBV | Feb 24, 2025 13 days to disclose | Good buy·+$5.4K+7.1% +6.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.9K+24.1% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$4.4K+54.9% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.7K+21.3% +18.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Bad buy·−$633-7.9% −10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2024 1.5y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Nov 20, 2024 1 day to disclose | Good buy·+$2.3K+28.5% +24.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |